Health and safety

  • , ,

    Synthetic bio success in anti-malaria drug

    .

    The blog does not usually cover the pharmaceuticals market being that I am unfamiliar with the players and the products in this industry. However, this news coming from University of California Berkeley warrants a post as professor of chemical engineering Jay Keasling — also the co-founder of Amyris, announced that France-based pharmaceutical company Sanofi will…